Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01730144 · ClinicalTrials.gov registry record
Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults
A clinical trial of Normal Physiology, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 10
- Enrollment target
- 1
- Study location
NCT01730144 is a study of Normal Physiology that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 10 participants, below the 1,292-participant average among 25 other Normal Physiology trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01730144, a study of Normal Physiology, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- One form of the influenza vaccine is a nasal spray. It uses a live but weakened flu virus. Researchers want to better under how the live vaccine interacts with the body s immune system. They will test the nasal spray flu vaccine (called FluMist) against a saline (salt water) nasal spray. They will then look at blood and nasal cell samples to see how the vaccine affects these cells immune response. Objectives: \- To look at immune changes in nasal and blood cells in people who receive live flu vaccine. Eligibility: \- Healthy volunteers between 18 and 49 years of age. Design: * Participants will have five outpatient visits for this study. Each visit will last up to 2 hours. * At the first visit, participants will have a physical exam and medical history. They will give blood and urine samples. Nasal cell samples will also be collected. * A week later, participants will have either the nasal spray flu vaccine or a saline spray. They will know which spray they will receive. Blood samples will be collected. * Two days after the vaccination, they will have another physical exam. Blood and nasal cell samples will be collected. * At the final two visits (1 week and 1 month after the vaccination), more blood samples will be collected. * Those who had the saline spray will be able to have the actual vaccine spray at the last study visit. * The ratio of participants who receive vaccine to those who receive saline will be 4:1.
Conditions Studied
Study Locations (1)
Maryland
- National Institutes of Health Clinical Center, 9000 Rockville Pike - Bethesda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2012-11-17 |
| Est. Completion | 2019-07-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01730144
The ClinicalTrials.gov registry entry for NCT01730144 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,292-participant average among 25 other Normal Physiology trials with a reported enrollment target (99% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Normal Physiology appearing as the primary indexed condition, and to 0 interventions.
NCT01730144 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT01730144 about?
NCT01730144 is a clinical study titled "Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults". Background: \- One form of the influenza vaccine is a nasal spray. It uses a live but weakened flu virus. Researchers want to better under how the live vaccine interacts with the body s immune system. They will test the nasal spray flu vaccine (called FluMist) against a saline (salt water) nasal sp...
What is the current status of trial NCT01730144?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2012-11-17. Estimated completion is 2019-07-12.
What conditions does trial NCT01730144 study?
This clinical trial studies the following conditions: Normal Physiology.
Who is sponsoring clinical trial NCT01730144?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01730144 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Normal Physiology
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Investigating the Impact of Obesity on Pubertal Development in Girls
RECRUITING
-
Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction
RECRUITING · NA
-
Influence of Brain Oscillation-Dependent TMS on Motor Function
RECRUITING
-
Sociocultural & Biobehavioral Influences on Pain Expression and Assessment
RECRUITING · NA
-
Clinical and Scientific Assessment of Pain and Painful Disorders
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.